Lincoln Research has rebranded as BTC of Lincoln and is now part of the BTC Network research group! Stay tuned for a brand new website coming soon.

 

Major Depression

Depression

Have you been diagnosed with clinical depression? Could you help us study a potential new antidepressant?

The RESET study is investigating if an FDA-approved antidepressant can help prevent future episodes of major depression.

You may be able to take part in the RESET Study if:

  • You are between 18 and 75 years of age;
  • You have been diagnosed with major depression that is considered moderate to severe;
  • You currently have depression that has lasted 2-18 months;
  • You have experienced at least two previous episodes of depression.

If you are eligible for the study you will receive FDA-approved medication for depression for up to 16 weeks. If after this period you continue to meet eligibility criteria, the next part of the study will look at whether the medication can prevent further episodes of depression for up to 32 weeks.

Call our office to see if the RESET study may be right for you!

 

Contact Us

Migraine

Spartan Study

Do you suffer from 3 to 8 migraines per month?

If so, consider joining SPARTAN--a clinical study to assess a potential new migraine medication for people like you. We're looking for people over 18 years of age to take part.

Although all migraine sufferers are welcome to contact us, we'd especially like to hear from migraine sufferers with at least one of the following:

  • High blood pressure;
  • High cholesterol;
  • A smoker;
  • Overweight;
  • Diabetes;
  • Family history of coronary artery disease;
  • Female and post-menopause;
  • Male and over 40 years of age.

Call our office to see if this clinical trial may be appropriate for you!

 

Contact Us

Bipolar Disorder

Bipolar Disorder

Are you suffering from Bipolar Disorder?

If so, you may qualify to participate in a research study seeking participants that suffer from Bipolar Depression.

The study is evaluating a potential new treatment for Bipolar Depression, and will last approximately twelve months. We're interested in hearing from people:

  • Between 18 and 65 years of age;
  • Who suffer from Bipolar Depression and have had manic or mixed episodes in the past;
  • Who are currently depressed and have been depressed for at least 4 weeks.

By choosing to participate, you may receive a consultation with a psychiatrist, a physical exam and blood tests, and compensation for time and travel.

Call our office to see if this clinical trial may be appropriate for you!

 

Contact Us

Adults With Migraine Headaches

Migraine

Local doctors are looking for people who experience migraines and who may be taking a preventative medication to treat migraines.

To qualify for this study, you must:

  • Have recently started taking a preventative medication to treat migraines (or will be starting to take one);
  • Be between 18 and 65 years of age
  • Have a history of migraines for 1 year or more prior to the study
  • Have at least 4 days of migraines per month for 3 months prior to the study
  • Meet other study eligibility criteria

If you qualify, compensation will be provided for study participation.

 

Contact Us

Schizophrenia

Schizophrenia

Are you or a loved one currently taking Invega Sustenna (paliperidone palmitate) for the treatment of schizophrenia and not having an adequate response?

This study is investigating whether a newly FDA-approved medicine may provide adequate treatment for your symptoms of schizophrenia.

To be eligible for this study, you must:

  • Be 18 to 65 years of age
  • Have a diagnosis of schizophrenia
  • Have received at least 3 doses of Invega Sustenna (paliperidone palmitate) prior to the study

Call our office to see if this clinical trial may be appropriate for you!

 

Contact Us

Lincoln Research offers clinical research studies at our Lincoln, RI location. We service communities in Rhode Island (RI) and Massachusetts (MA).

 

Exterior photo

If interested in participating or learning more about a clinical study with Lincoln Research, please call 401.305.5200.

Inquire About a Study